FLT3 and acute myeloid leukemia: A total of 183 patients with FLT3-ITD-mutated R/R AML received a FLT3i-based treatment for the first time in a salvage setting, of whom 89 received a second, 25 a third, and only 4 a fourth sequential FLT3i-based treatment (Table 2).